Related Experiment Videos
Intelligent use of NSAIDs--where do we stand?
1University of North Carolina, Chapel Hill, NC 27514, USA. rberger@unch.unc.edu
Expert Opinion on Pharmacotherapy
|May 5, 2001
Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) are effective for inflammatory conditions but carry risks. Selective COX-2 inhibitors offer reduced GI toxicity but still impact renal function, necessitating careful patient selection.
Area of Science:
- Pharmacology
- Rheumatology
- Internal Medicine
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for various medical conditions.
- While effective for inflammation, NSAIDs present significant gastrointestinal (GI), renal, and haematological toxicities.
- Cyclooxygenase-(COX)-2 selective NSAIDs offer reduced GI risks and no effect on platelet function, but retain renal physiological effects.
Purpose of the Study:
- To evaluate the comparative efficacy and safety of NSAIDs.
- To determine the appropriate use of NSAIDs in inflammatory and non-inflammatory rheumatic conditions.
- To guide the selection of NSAIDs, particularly COX-2 selective agents, and consider alternatives in specific patient populations.
Main Methods:
- Review of clinical evidence and pharmacological profiles of NSAIDs.
- Analysis of comparative studies on NSAID efficacy in musculoskeletal and rheumatic conditions.
- Assessment of toxicity profiles, including GI, renal, and haematological effects.
Main Results:
- No definitive clinical superiority of one NSAID over another in musculoskeletal conditions.
- NSAIDs are not demonstrably more effective than simple analgesics for non-inflammatory rheumatic conditions.
- Selective COX-2 agents are recommended as first-choice therapy for inflammatory rheumatic diseases when economically feasible.
Conclusions:
- NSAIDs are indicated for primary therapy of inflammatory rheumatic diseases.
- Selective COX-2 inhibitors should be considered first-line agents for inflammatory rheumatic conditions if cost-effective.
- Indiscriminate use of NSAIDs for non-inflammatory osteoarthritis or musculoskeletal injuries, especially in the elderly, should be avoided in favor of less toxic alternatives.